Duangnate Rojanaporn - research works

Of 106 patients included, the mean (range) age at diagnosis was 51.6 (16-86) years.

The most common tumor location was the choroid (n = 100, 94.3%), followed by the ciliary body (n = 4, 3.8%) and iris (n = 2, 1.9%).

AJCC tumor staging was T1 in 18.9%, T2 in 17.9%, T3 in 48.1%, and T4 in 15.1% of cases.

The incidence of melanoma-related death was 3.4 per 100 person-years, increasing with tumor stage.

Most experts agreed on the suggested classification, diagnosis, and prognosis.

The controversy, however, remained in questions regarding association with other vascular disorders, treatment of stages 3 and 4, possible benefits of newer anti-VEGF agents, and the role of artificial intelligence.

Of 46 eyes, 21 (46%) were diagnosed with small to medium choroidal melanoma, 13 (28%) with retinoblastoma, 4 (9%) with choroidal metastases, 2 (4%) with retinal vasoproliferative tumor (VPT), 3 (7%) with choroidal hemangioma (CH), 2 (4%) with RPE adenoma, and 1 (2%) with retinal hemangioblastoma.

The mean tumor thickness was 4.8 mm (range, 2.4-6.6).

Radiation-related complications were found in 28 eyes (61%), including cataracts in 10 (25%), radiation retinopathy in 14 (30%), radiation maculopathy in 14 (30%), radiation papillopathy in 6 (13%), and vitreous hemorrhage in 3 (7%) eyes.

All patients with retinoblastoma currently alive without metastasis.